Farmacología en la tercera edad: Medicamentos de uso continuo y peligros de la interacción medicamentosa

dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorHaddad, Marcela Filié
dc.creatorTakamiya, Aline Satie
dc.creatorda Silva, Eulália Maria Martins
dc.creatorBarbosa, Débora de Barros
dc.date2014-05-27T11:24:00Z
dc.date2016-10-25T18:27:30Z
dc.date2014-05-27T11:24:00Z
dc.date2016-10-25T18:27:30Z
dc.date2009-10-19
dc.date.accessioned2017-04-06T01:37:28Z
dc.date.available2017-04-06T01:37:28Z
dc.identifierGerokomos, v. 20, n. 1, p. 22-27, 2009.
dc.identifier1134-928X
dc.identifierhttp://hdl.handle.net/11449/71199
dc.identifierhttp://acervodigital.unesp.br/handle/11449/71199
dc.identifier10.4321/S1134-928X2009000100004
dc.identifierS1134-928X2009000100004
dc.identifier2-s2.0-70349976092.pdf
dc.identifier2-s2.0-70349976092
dc.identifierhttp://dx.doi.org/10.4321/S1134-928X2009000100004
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/892207
dc.descriptionIntroduction: It was observed a considerable growth of elderly people. They are who use more medicines. The physiological changes associated with the age advancing can make pharmacokinetic and pharmacodynamic alterations. The cognitive decline, physical limitations and associate chronic pathology affect the medications appropriately use ability. Aims: Based in a literature review, appoint the main pharmacological groups prescribed to the elderly and the drug-drug interaction risks. Conclusion: The most of elderly use continually at least 3 medicines, the most prescribed are to cardiovascular and psychic diseases treatment.
dc.languagespa
dc.relationGerokomos
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectContinuous use medicines
dc.subjectDrug-drug interaction
dc.subjectElderly
dc.subjectacetylsalicylic acid
dc.subjectamitriptyline
dc.subjectanalgesic agent
dc.subjectantacid agent
dc.subjectantihypertensive agent
dc.subjectantiinflammatory agent
dc.subjectantiulcer agent
dc.subjectanxiolytic agent
dc.subjectbeta adrenergic receptor blocking agent
dc.subjectbromazepam
dc.subjectcalcium channel blocking agent
dc.subjectchlordiazepoxide
dc.subjectchlorpropamide
dc.subjectclomipramine
dc.subjectdiazepam
dc.subjectdiclofenac
dc.subjectdiltiazem
dc.subjectdipeptidyl carboxypeptidase inhibitor
dc.subjectdiuretic agent
dc.subjectflurazepam
dc.subjectfurosemide
dc.subjectheparin
dc.subjectmethyldopa
dc.subjectmineral
dc.subjectneuroleptic agent
dc.subjectnifedipine
dc.subjectnitrazepam
dc.subjectphenylbutazone
dc.subjectunindexed drug
dc.subjectvitamin
dc.subjectaged
dc.subjectaging
dc.subjectcardiovascular disease
dc.subjectdrug safety
dc.subjectdrug use
dc.subjectelderly care
dc.subjecthuman
dc.subjectmental disease
dc.subjectpharmacodynamics
dc.subjectprescription
dc.subjectrisk assessment
dc.subjectsocial psychology
dc.subjectunspecified side effect
dc.titleFarmacología en la tercera edad: Medicamentos de uso continuo y peligros de la interacción medicamentosa
dc.typeOtro


Este ítem pertenece a la siguiente institución